Hacker News Reader

As others have stated this is not what the article/study states, also speed is related to a street drug with unknown dosage and control. While the prescribed pharmaceutical-grade medication is precise and well managed with slow release mechanism, making it vastly different from the street drug.

I wouldnt call it vastly different. It cant be abused for euphoria, but it still has an addiction warning on the label.

I'm on methylphenidate and if it were addictive I wouldn't forget to take them... well, probably pretty much ever, unless I misunderstand addiction. In reality I forget to take them once or twice a week.

I recently started using one of day-of-the-week pillboxes, so I can tell you this week it was Tuesday.

> I'm on methylphenidate and if it were addictive I wouldn't forget to take them...

but youve got ADHD and one of the symptoms is "i forget selective things", therefore you definitely could forget

> I recently started using one of day-of-the-week pillboxes

This is the way. I would absolutely forget to take my Adderall if it weren't in a pillbox next to my toothbrush.

> It cant be abused for euphoria

Depends on the drug, vyvanse can't really be, but focalin can.

What's great about this comment is it gets two things wrong: the conclusion of the study (which found reductions across the board in fuckedupedness) and the drug being studied (Ritalin, not Adderall i.e. "speed")

I don't think the article is saying what you think it's saying:

> Drug treatment for ADHD was associated with beneficial effects in reducing the risks of suicidal behaviours, substance misuse, transport accidents, and criminality but not accidental injuries when considering first event rate. The risk reductions were more pronounced for recurrent events, with reduced rates for all five outcomes. This target trial emulation study using national register data provides evidence that is representative of patients in routine clinical settings.

That’s the opposite of the conclusion, though?

> Drug treatment for ADHD was associated with beneficial effects in reducing the risks of suicidal behaviours, substance misuse, transport accidents, and criminality but not accidental injuries when considering first event rate. The risk reductions were more pronounced for recurrent events, with reduced rates for all five outcomes. This target trial emulation study using national register data provides evidence that is representative of patients in routine clinical settings.

maybe if you took your speed you would have understood the paper